Scorpion venom stings cancer
While the sting of most scorpions is nonlethal to humans, it's not usually considered health-enhancing either. But the venom could actually prove lifesaving.
While the sting of most scorpions is nonlethal to humans, it's not usually considered health-enhancing either. But the venom could actually prove lifesaving.
Dr. James M. Olson and colleagues at the Fred Hutchinson Cancer Research Center in Seattle attached the peptide chlorotoxin to Cy5.5, a fluorescent molecule that emits near-infrared light. Chlorotoxin, a component of scorpion venom, preferentially binds to cancer cells (Cancer Res 2007;67:6882-6888).
The probe lit up malignant gliomas, medulloblastomas, prostate cancer, intestinal cancer, and sarcomas. Brain tumors as small as 1 mm in diameter and as few as 200 metastatic prostate cancer cells were visualized.
The unique contrast agent shows promise for imaging melanoma and skin, esophageal, cervical, lung, and colon cancers. It binds to cancer cells within minutes after injection, but its signal can be detected for 14 days. Iron oxide-based nanoparticles coated with chlorotoxin imaging are being developed for use with MR.
Emerging AI Mammography Model May Enhance Clarity for Initial BI-RADS 3 and 4 Classifications
May 21st 2025In a study involving over 12,000 Asian women, researchers found that an artificial intelligence (AI) model converted over 83 percent of false positives in patients with initial BI-RADS 3 and 4 assessments into benign BI-RADS categories.
Study: Abbreviated Breast MRI Offers Equivalent Accuracy to mpMRI for Women with Dense Breasts
May 20th 2025Emerging research suggests that abbreviated breast MRI offers comparable sensitivity and specificity as multiparametric MRI in women with extremely dense breasts with a nearly 50 percent reduction in reading time for radiologists.
Can AI Predict Future Lung Cancer Risk from a Single CT Scan?
May 19th 2025In never-smokers, deep learning assessment of single baseline low-dose computed tomography (CT) scans demonstrated a 79 percent AUC for predicting lung cancer up to six years later, according to new research presented today at the American Thoracic Society (ATS) 2025 International Conference.
